Company intelligence / Profile preview
Advanced Imaging Projects
Lake Worth, Florida, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Advanced Imaging Projects LLC develops diagnostic and therapeutic radiopharmaceuticals targeting oncology and nervous system diseases. Its lead asset, 18F-Fluoromisonidazole, is in Phase 2 for hepatocellular carcinoma; other programs are at preclinical or contrast agent development stages. The company focuses on integrin-targeted agents for both diagnosis and therapy in cancer indications. No published clinical results were found as of early 2025.
- Therapeutic areas
- OncologyOther
- Modalities
- Diagnostic radiopharmaceuticalsTherapeutic radiopharmaceuticalsSmall molecule drugPeptide conjugate radionuclide
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Advanced Imaging Projects.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advanced Imaging Projects.